Blepharitis historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 34: Line 34:
In 1991, Mathers et al. classified meibomian gland dysfunction based on meibomian gland morphology, tear osmolarity, and Schirmer test: 1) seborrheic, 2) obstructive, 3) obstructive with sicca, and 4) sicca.<ref>Mathers, William D., et al. "Meibomian gland dysfunction in chronic blepharitis." Cornea 10.4 (1991): 277-285.</ref> Bron et al. utilized morphologic features on slit-lamp biomicroscopy to categorize meibomian gland diseases.<ref>Bron, A. J., L. Benjamin, and G. R. Snibson. "Meibomian gland disease. Classification and grading of lid changes." Eye 5.Pt 4 (1991): 395-411.</ref>  
In 1991, Mathers et al. classified meibomian gland dysfunction based on meibomian gland morphology, tear osmolarity, and Schirmer test: 1) seborrheic, 2) obstructive, 3) obstructive with sicca, and 4) sicca.<ref>Mathers, William D., et al. "Meibomian gland dysfunction in chronic blepharitis." Cornea 10.4 (1991): 277-285.</ref> Bron et al. utilized morphologic features on slit-lamp biomicroscopy to categorize meibomian gland diseases.<ref>Bron, A. J., L. Benjamin, and G. R. Snibson. "Meibomian gland disease. Classification and grading of lid changes." Eye 5.Pt 4 (1991): 395-411.</ref>  


In 2003, Foulks and Bron devised a classification system for meibomian glad dysfunction that integrated anatomic changes, gland expressibility, biochemical alterations of meibomian gland lipids, and the underlying etiology.
In 2003, Foulks and Bron devised a classification for meibomian glad dysfunction that integrated anatomic changes, gland expressibility, biochemical alterations of meibomian gland lipids, and the underlying etiology.


More recently in 2011, the International Workshop on Meibomian Gland Dysfunction presented a classification system that distinguishes among the subgroups on the basis of the level of secretions and further subdivides those categories by potential consequences and manifestations.<ref>Nelson, J. Daniel, et al. "The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee." Investigative ophthalmology & visual science 52.4 (2011): 1930-1937.</ref>
In 2011, the International Workshop on Meibomian Gland Dysfunction presented a classification system that distinguishes among the subgroups on the basis of the level of secretions and further subdivides those categories by potential consequences and manifestations.<ref>Nelson, J. Daniel, et al. "The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee." Investigative ophthalmology & visual science 52.4 (2011): 1930-1937.</ref>


==References==
==References==

Revision as of 21:26, 27 July 2016

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis historical perspective On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis historical perspective

CDC on Blepharitis historical perspective

Blepharitis historical perspective in the news

Blogs on Blepharitis historical perspective

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Blepharitis was first described in the late 19th century as "conjunctivitis meibomianae" in a patient with accumulated sebaceous-like material in the meibomian glands.

Historical Perspective

Terminology

The terminology for blepharitis has evolved alongside the advance in its pathophysiology and treatment. Early terms used to describe related meibomian gland conditions include ophthalmia tarsi, puriform palpebral flux, polyadenitis meibomiana chronica suppurativa, conjunctivitis meibomianae, meibomian seborrhea, keratitis meibomiana, seborrheic blepharoconjunctivitis, meibomian keratoconjunctivitis, meibomianitis, and meibomitis.

The earliest description of blepharitis dates back to 1894, when Lydston reported the clinical entity "conjunctivitis meibomianae" in a patient with accumulated sebaceous-like material in the meibomian glands.[1]

In 1901, Maklahoff reported another case characterized by dilated meibomian gland openings with pus formation in the glands.[2]

In 1908, Elschnig described the symptom of meibomian gland hypersecretion which could be relieved by emptying of the glands and the use of astringents.[3]

In 1921, Gifford isolated Staphylococcus aureus and Bacillus xerosis from meibomian gland cultures of young and elderly individuals, respectively.[4]

In 1942, Scobee noted frequent isolation of staphylococci from meibomian gland cultures in both patients and normal controls.[5] This finding suggested that colonization of microorganisms may play a role in the pathogenesis. Scobee also recommended the use of lid massage and adrenalin in conjunction with antiseptic eyedrops to promote drainage of the meibomian glands.

Several terms indicating the site of involvement have been used extensively in the later studies. The term "meibomian gland dysfunction", suggested by Gutgesell et al. in 1982, gained general acceptance and has been used to describe the spectrum of meibomian gland abnormalities leading to blepharitis.[6]

Classification

Several classifications have been developed on the basis of etiology, clinical manifestations, meibography findings, tear osmolarity, and Schirmer testing.

In 1921, Gifford proposed the earliest classification of blepharitis, which divided chronic meibomian gland disease into six categories: 1) hypersecretion, 2) chronic meibomitis, 3) chronic meibomitis with hypertrophy, 4) chronic meibomitis with chalazia, 5) chronic meibomitis secondary to chronic conjunctivitis, and 6) chronic meibomitis with concretions.[7]

In 1946, Thygeson developed a classification system according to the etiology: 1) seborrheic, 2) staphylococcal, 3) mixed seborrheic and staphylococcal, and 4) blepharitis due to Hemophilus duplex.[8]

In 1982, the classification was superseded by a more precise scheme developed by McCulley et al. on the basis of clinical criteria: 1) staphylococcal, 2) seborrheic, 3) mixed seborrheic/staphylococcal, 4) seborrheic with meibomian seborrhea, 5) seborrheic with secondary meibomitis, 6) primary meibomitis (also known as meibomian keratoconjunctivitis), and 7) other including atopic, psoriatic, and fungal.[9]

In 1991, Mathers et al. classified meibomian gland dysfunction based on meibomian gland morphology, tear osmolarity, and Schirmer test: 1) seborrheic, 2) obstructive, 3) obstructive with sicca, and 4) sicca.[10] Bron et al. utilized morphologic features on slit-lamp biomicroscopy to categorize meibomian gland diseases.[11]

In 2003, Foulks and Bron devised a classification for meibomian glad dysfunction that integrated anatomic changes, gland expressibility, biochemical alterations of meibomian gland lipids, and the underlying etiology.

In 2011, the International Workshop on Meibomian Gland Dysfunction presented a classification system that distinguishes among the subgroups on the basis of the level of secretions and further subdivides those categories by potential consequences and manifestations.[12]

References

  1. Lydston, James A. "CONJUNCTIVITIS MEIBOMIANÆ." Journal of the American Medical Association 23.6 (1894): 241-242.
  2. Maklahoff, AA. "Zur Bactderchron eitrigen Entzund der Gland Meib des Lides." Arch fur Augenheilkd. 13.10 (1901).
  3. Elschnig, A. "Beitrag zur Aethiologie und Therapie der cronischen Konjunctivitis." Deuts Med Wochenschr 26 (1908): 1133-1135.
  4. Gifford, Sanford R. "The etiology of chronic meibomitis." American Journal of Ophthalmology 4.8 (1921): 566-570.
  5. Scobee, Richard G. "The Role of the Meibomian Glands in Recurrent Conjunctivitis: A Review with Experimental Observations." American Journal of Ophthalmology 25.2 (1942): 184-192.
  6. Gutgesell, Vicki J., George A. Stern, and C. Ian Hood. "Histopathology of meibomian gland dysfunction." American journal of ophthalmology 94.3 (1982): 383-387.
  7. Gifford, Sanford R. "Meibomian glands in chronic blepharo-conjunctivitis." American Journal of Ophthalmology 4.7 (1921): 489-494.
  8. Thygeson, Phillips. "Etiology and treatment of blepharitis: a study in military personnel." Archives of Ophthalmology 36.4 (1946): 445-477.
  9. McCulley, James P., Joel M. Dougherty, and David G. Deneau. "Classification of chronic blepharitis." Ophthalmology 89.10 (1982): 1173-1180.
  10. Mathers, William D., et al. "Meibomian gland dysfunction in chronic blepharitis." Cornea 10.4 (1991): 277-285.
  11. Bron, A. J., L. Benjamin, and G. R. Snibson. "Meibomian gland disease. Classification and grading of lid changes." Eye 5.Pt 4 (1991): 395-411.
  12. Nelson, J. Daniel, et al. "The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee." Investigative ophthalmology & visual science 52.4 (2011): 1930-1937.